FDA Greenlights RevBio's Pivotal Clinical Trial for its Cranial Flap Bone Glue

RevBio, Inc., announced that it has received investigational device exemption (IDE) approval from the FDA to conduct a multi-center randomized controlled pivotal clinical trial to use TETRANITE (R) to ...
Business Wire

RevBio Receives a $2.4 Million NIH Grant to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation and Enrolls First Five Patients

This Clinical Trial will Show Preliminary Safety and Probable Benefit of TETRANITE ® for Replacing the Use of Metal Plates and Screws LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it ...
Business Wire

RevBio Receives FDA Approval to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation

LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a 20-patient pilot clinical trial to examine the safety and ...
News Medical

3D-printed bone: Biomimetic scaffolds offer hope for cranial defect repair

The cranial bone in the human body performs very important functions, such as protecting the brain and enabling the passage of the cranial nerves that are essential to physiological functioning.